Artículos de revistas sobre el tema "M. tuberculosis - Rifampicin"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "M. tuberculosis - Rifampicin".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Danlami, Mohammed Bashar, Basiru Aliyu y Grace Samuel. "INCIDENCE OF RIFAMPICIN-RESISTANCE PRESUMPTIVE M. TUBERCULOSIS CASES AMONG OUTPATIENTS IN KEBBI STATE, NIGERIA". African Journal of Infectious Diseases 15, n.º 1 (15 de diciembre de 2020): 47–52. http://dx.doi.org/10.21010/ajid.v15i1.6.
Texto completode la Iglesia, Agustina I., Emma J. Stella y Héctor R. Morbidoni. "Comparison of the Performances of Two In-House Rapid Methods for Antitubercular Drug Susceptibility Testing". Antimicrobial Agents and Chemotherapy 53, n.º 2 (17 de noviembre de 2008): 808–10. http://dx.doi.org/10.1128/aac.00960-08.
Texto completoАХМЕТОВА, А. Ж., Ж. М. АБИЛОВА, Г. Н. ЖАРЫЛҚАСЫН, А. Р. АКИЛЬЖАНОВА y У. А. КОЖАМКУЛОВ. "ҚАЗАҚСТАНДА ТАРАЛҒАН РИФАМПИЦИН-ТӨЗІМДІ M. TUBERCULOSIS КЛИНИКАЛЫҚ ИЗОЛЯТТАРЫНЫҢ ГЕНЕТИКАЛЫҚ СИПАТТАМАСЫ". Vestnik, n.º 1(64) (14 de abril de 2023): 53–65. http://dx.doi.org/10.53065/j5985-7576-8270-u.
Texto completoGautam, Praveen B., Ashwini Mishra y Santosh Kumar. "Prevalence of rifampicin resistant mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients in eastern Uttar Pradesh: a cross sectional study". International Journal Of Community Medicine And Public Health 5, n.º 6 (22 de mayo de 2018): 2271. http://dx.doi.org/10.18203/2394-6040.ijcmph20182039.
Texto completoSanzhakov, M. A., O. M. Ipatova, T. I. Torkhovskaya, E. G. Tikhonova, N. V. Medvedeva, T. S. Zakharova y V. N. Prozorovskiy. "Increase of antituberculosis efficiency of rifampicin embedded into phospholipid nanoparticles with sodium oleate". Biomeditsinskaya Khimiya 64, n.º 6 (2018): 505–10. http://dx.doi.org/10.18097/pbmc20186406505.
Texto completoNotopuro, P. B., J. Nugraha y H. Notopuro. "DETEKSI MOLEKUL MUTASI GEN rpoB MYCOBACTERIUM TUBERCULO SIS PADA DAHAK DENGAN POL YME RASE CHAIN REACTION DAN SINGLE STRAND CONFORMATION POLYMORPHISM". INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 16, n.º 2 (16 de marzo de 2018): 81. http://dx.doi.org/10.24293/ijcpml.v16i2.973.
Texto completoN. Djide, Nana Juniarti, M. Natsir Djide, Muhammad Nur Amir y Sartini Sartini. "Aktivitas Antibakteri Ekstrak Kelopak Bunga Rosella Terenkapsulasi Maltodekstrin dan Sinergitasnya dengan Isoniazida dan Rifampisin Terhadap Mycobacterium tuberculosis H37rv". Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) 5, n.º 2 (15 de octubre de 2019): 117. http://dx.doi.org/10.22487/j24428744.0.v0.i0.12946.
Texto completoN. Djide, Nana Juniarti, M. Natsir Djide, Muhammad Nur Amir y Sartini Sartini. "Aktivitas Antibakteri Ekstrak Kelopak Bunga Rosella Terenkapsulasi Maltodekstrin dan Sinergitasnya dengan Isoniazida dan Rifampisin Terhadap Mycobacterium tuberculosis H37rv". Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) 5, n.º 2 (15 de octubre de 2019): 117–23. http://dx.doi.org/10.22487/j24428744.2019.v5.i2.12946.
Texto completoMohiuddin, Md y J. Ashraful Haq. "First Line Anti-Tubercular Drug Resistance Pattern of Mycobacterium Tuberculosis Isolated From Specialized Hospitals of Dhaka City". Ibrahim Medical College Journal 8, n.º 2 (4 de febrero de 2016): 41–46. http://dx.doi.org/10.3329/imcj.v8i2.26677.
Texto completoKashyap, Bineeta, Nisha Goyal, Puneeta Hyanki, NP Singh y Ashwani Khanna. "Cartridge-based nucleic acid amplification test: a novel rapid diagnostic tool to study the burden of tuberculosis from a tertiary care hospital". Tropical Doctor 49, n.º 4 (10 de julio de 2019): 274–81. http://dx.doi.org/10.1177/0049475519859958.
Texto completoZahoor, Danish, Shameem Wani y Zaffer Nowshad Wani. "Evaluation of cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampicin resistance in clinical specimen". International Journal of Research in Medical Sciences 7, n.º 6 (29 de mayo de 2019): 2121. http://dx.doi.org/10.18203/2320-6012.ijrms20192484.
Texto completoLaskar, Nourjahan, Md Akram Hossain, Jannatul Fardows y Mominur Rahman. "GeneXpert MTB/RIF Assay for Rapid Identification of Mycobacterium Tuberculosis and Rifampicin Resistance Directly from Sputum Sample". Journal of Enam Medical College 7, n.º 2 (4 de junio de 2017): 86–89. http://dx.doi.org/10.3329/jemc.v7i2.32653.
Texto completoHuey, Lee Lih, Chua Wei Chuan, Zeti Norfidiyati Ayub Salmuna, Norazmi Mohd Nor, Alwi Muhd Besari and Chan y Yean Yean. "A novel two-codon deletion at codon 508 and 509 of the rpoB gene in pulmonary tuberculosis and HIV co-infection: A case report". Pakistan Journal of Medical and Health Sciences 16, n.º 7 (30 de julio de 2022): 201–2. http://dx.doi.org/10.53350/pjmhs22167201.
Texto completoTesic, Jelena, Zorica Lepsanovic y Veljko Mirovic. "Evaluation of usefulness of single-strand conformation polymorphism method for rapid detection of rifampicin-resistant mycobacterium tuberculosis". Vojnosanitetski pregled 61, n.º 2 (2004): 169–72. http://dx.doi.org/10.2298/vsp0402169t.
Texto completoRiwu, Audrey Gracelia, Jusak Nugaraha y Yoes Prijatna Dachlan. "DIFFERENCES OF INTERLEUKIN-18 AND INTERLEUKIN-10 LEVELS IN RIFAMPICIN RESISTANT AND RIFAMPICIN SENSITIVE PULMONARY TUBERCULOSIS PATIENTS IN DR. SOETOMO HOSPITAL SURABAYA". Indonesian Journal of Tropical and Infectious Disease 8, n.º 2 (31 de julio de 2020): 116. http://dx.doi.org/10.20473/ijtid.v8i2.10959.
Texto completoJiang, Haiqin, Lemuel Tsang, Hongsheng Wang y Changhong Liu. "IFI44L as a Forward Regulator Enhancing Host Antituberculosis Responses". Journal of Immunology Research 2021 (20 de octubre de 2021): 1–12. http://dx.doi.org/10.1155/2021/5599408.
Texto completoZeng, Sheng, Dong Yang, Céline Rens y Véronique Fontaine. "The Mycobacterium bovis BCG GroEL1 Contributes to Isoniazid Tolerance in a Dormant-Like State Model". Microorganisms 11, n.º 2 (21 de enero de 2023): 286. http://dx.doi.org/10.3390/microorganisms11020286.
Texto completoSabaté, M. Betriu, A. González-Rodríguez, A. Guàrdia, E. Pérez-Macho, A. Alvarez Pedrero, S. Acebillo, J. A. Monreal, D. Palao Vidal y J. Labad. "Pharmacokinetic interactions of psychotropic medications in patients with schizophrenia suffering from atypical mycobacterial infections". European Psychiatry 64, S1 (abril de 2021): S649—S650. http://dx.doi.org/10.1192/j.eurpsy.2021.1725.
Texto completoRahman, Fahmida, Sadia Sharmin, Md Mustafa Kamal y Md Ruhul Amin Miah. "Drug resistance pattern of M. tuberculosis in category II treatment failure pulmonary tuberculosis patients". Ibrahim Medical College Journal 7, n.º 1 (20 de enero de 2014): 9–11. http://dx.doi.org/10.3329/imcj.v7i1.17741.
Texto completoMurthy, Neetha S., Sanjeev Nair, PK Ramya, Renu Susan George, B. Ravikrishnan, M. Sunil Kumar, Sairu Philip, PS Rakesh y Shibu Balakrishnan. "Drug-resistant Tuberculosis: First Line Drug Resistance Pattern among Mycobacterium Tuberculosis Strains Isolated from a Reference Laboratory in Kerala State, India". Journal of Pure and Applied Microbiology 15, n.º 4 (4 de octubre de 2021): 1882–91. http://dx.doi.org/10.22207/jpam.15.4.09.
Texto completoGarg, Saurabh, Rakesh Kumar, Dennis Kunimoto y Gina R. Rayat. "Anti-Mycobacterial Activity of Flavonoid and Pyrimidine Compounds". Molecules 27, n.º 19 (9 de octubre de 2022): 6714. http://dx.doi.org/10.3390/molecules27196714.
Texto completoCoban, Ahmet Yilmaz. "A novel agar base medium for drug susceptibility testing of Mycobacterium tuberculosis isolates". Future Microbiology 16, n.º 13 (septiembre de 2021): 949–53. http://dx.doi.org/10.2217/fmb-2021-0032.
Texto completoZhurilo, A. A., A. I. Barbova, Yu A. Cherednik, P. S. Trofimova, S. V. Mironchenko, O. V. Pavlova, A. V. Chernov y L. M. Sladkova. "COMPARISON OF GENEXPERT MTB/RIF AND GENOTYPE SYSTEMS WITH MTBDRPLUS STRIPS FOR DETECTION OF MUTATIONS THAT ARE ASSOCIATED WITH M. TUBERCULOSIS RESISTANCE TO RIFAMPICIN IN TUBERCULOSIS". Ukrainian Pulmonology Journal 30, n.º 4 (2022): 34–41. http://dx.doi.org/10.31215/2306-4927-2022-30-4-34-41.
Texto completoKumar Sah, Ranjit, Dwij Raj Bhatta, Gokarna Raj Ghimire, Bhuwaneswor Prasad Kandel, Bishnu Raj Tiwari y Jeevan Bahadur Sherchand. "Evaluation of Nitrate Reductase Assay For Rapid Detection of Drug Resistant Tuberculosis". Journal of Health and Allied Sciences 3, n.º 1 (24 de noviembre de 2019): 44–46. http://dx.doi.org/10.37107/jhas.53.
Texto completoAndreevskaya, S. N., T. G. Smirnova, E. E. Larionova, I. Yu Andrievskaya, L. N. Chernousova y A. Ergeshov. "Isoniazid-resistant Mycobacterium tuberculosis: prevalence, resistance spectrum and genetic determinants of resistance". Bulletin of Russian State Medical University, n.º (1)2020 (12 de enero de 2020): 21–26. http://dx.doi.org/10.24075/brsmu.2020.001.
Texto completoSantos, Nathally C. de S., Regiane B. de L. Scodro, Dayane CB Leal, Silvia MT do Prado, Daniela F. Micheletti, Eloísa G. Sampiron, Giovana F. Costacurta et al. "Determination of minimum bactericidal concentration, in single or combination drugs, against Mycobacterium tuberculosis". Future Microbiology 15, n.º 2 (enero de 2020): 107–14. http://dx.doi.org/10.2217/fmb-2019-0050.
Texto completoSah, Ranjit Kumar, DR Bhatta, GR Ghimire, BP Kandel, BR Tiwari y JB Sherchand. "Evaluation of Nitrate Reductase Assay for Rapid Detection of Drug Resistant Tuberculosis". SAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS 9, n.º 2 (23 de abril de 2013): 4–8. http://dx.doi.org/10.3126/saarctb.v9i2.7971.
Texto completoAl-Madhagi, Anwar K., Khaled A. Al-Moyed y Ahmed M. Al-Haddad. "Resistance of anti-tuberculosis drugs among pulmonary tuberculosis patients in Yemen". Journal of the Faculty of Medicine Baghdad 55, n.º 3 (1 de julio de 2013): 250–53. http://dx.doi.org/10.32007/jfacmedbagdad.553625.
Texto completoSuhas Kulkarni, Gauri y Chetan Mahajan. "Resistance to Isoniazid and Rifampicin and Factors Associated with Resistance Among MDR TB Patients Visiting DOTS PLUS Site". MVP Journal of Medical Sciences 4, n.º 1 (22 de mayo de 2017): 14. http://dx.doi.org/10.18311/mvpjms/0/v0/i0/14782.
Texto completoSolari, L., D. Santos-Lazaro y Z. M. Puyen. "Mutations in Mycobacterium tuberculosis Isolates with Discordant Results for Drug-Susceptibility Testing in Peru". International Journal of Microbiology 2020 (7 de abril de 2020): 1–5. http://dx.doi.org/10.1155/2020/8253546.
Texto completoCaminero, Jose y Charles Daley. "Management of Multidrug-Resistant Tuberculosis". Seminars in Respiratory and Critical Care Medicine 39, n.º 03 (junio de 2018): 310–24. http://dx.doi.org/10.1055/s-0038-1661383.
Texto completoAl-Mutairi, Noura M., Suhail Ahmad, Eiman Mokaddas y Sahal Al-Hajoj. "First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB". PLOS ONE 17, n.º 10 (20 de octubre de 2022): e0276487. http://dx.doi.org/10.1371/journal.pone.0276487.
Texto completoMADANIA, AMMAR, MAYA HABOUS, HANA ZARZOUR, IFAD GHOURY y BAREA HEBBO. "Characterization of Mutations Causing Rifampicin and Isoniazid Resistance of Mycobacterium tuberculosis in Syria". Polish Journal of Microbiology 61, n.º 1 (2012): 23–32. http://dx.doi.org/10.33073/pjm-2012-003.
Texto completoSalina, T. Yu y T. I. Morozova. "Prevalence and Patterns of Gene Mutations Associated with <i>M. tuberculosis</i> Resistance to Isoniazid and Rifampicin in Patients with Different Clinical Manifestations of Tuberculosis". Tuberculosis and Lung Diseases 101, n.º 1 (4 de marzo de 2023): 28–33. http://dx.doi.org/10.58838/2075-1230-2023-101-1-28-33.
Texto completoKrajewska-Wędzina, Monika, Anna Zabost, Ewa Augustynowicz-Kopeć, Marcin Weiner y Krzysztof Szulowski. "Evaluation of susceptibility to antimycobacterial drugs in Mycobacterium tuberculosis complex strains isolated from cattle in Poland". Journal of Veterinary Research 61, n.º 1 (1 de marzo de 2017): 23–26. http://dx.doi.org/10.1515/jvetres-2017-0003.
Texto completoAdmassu, Wasihun, Birhanu Ayelign, Gemeda Abebe y Mulualem Tadesse. "Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis cases at Jimma University Medical Center, Southwest Ethiopia". PLOS ONE 17, n.º 1 (27 de enero de 2022): e0262929. http://dx.doi.org/10.1371/journal.pone.0262929.
Texto completoKalani, Komal, Vinita Chaturvedi, Priyanka Trivedi, Sudeep Tondon y Santosh Kumar Srivastava. "Dihydroartemisinin and its Analogs: A New Class of Antitubercular Agents". Current Topics in Medicinal Chemistry 19, n.º 8 (3 de junio de 2019): 594–99. http://dx.doi.org/10.2174/1568026619666190304142802.
Texto completoUmpeleva, T. V., E. A. Mazurina, D. V. Vakhrusheva y N. I. Eremeeva. "Comparison of Different Methods for Drug Susceptibility Testing of Mycobacterium tuberculosis to Rifampicin". Tuberculosis and Lung Diseases 100, n.º 1 (11 de febrero de 2022): 41–48. http://dx.doi.org/10.21292/2075-1230-2022-100-1-41-48.
Texto completoDiriba, Getu, Abebaw Kebede, Habteyes Hailu Tola, Ayinalem Alemu, Bazezew Yenew, Shewki Moga, Desalegn Addise et al. "Utility of line probe assay in detecting drug resistance and the associated mutations in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia". SAGE Open Medicine 10 (enero de 2022): 205031212210982. http://dx.doi.org/10.1177/20503121221098241.
Texto completoKazakova, Oxana, Roxana Racoviceanu, Anastasiya Petrova, Marius Mioc, Adrian Militaru, Lucreția Udrescu, Mihai Udrescu et al. "New Investigations with Lupane Type A-Ring Azepane Triterpenoids for Antimycobacterial Drug Candidate Design". International Journal of Molecular Sciences 22, n.º 22 (21 de noviembre de 2021): 12542. http://dx.doi.org/10.3390/ijms222212542.
Texto completoSanzhakov, M. A., O. M. Ipatova, V. N. Prozorovskiy, N. V. Medvedeva y T. I. Torkhovskaya. "Interaction of rifampicin embedded in phospholipid nanoparticles with blood plasma lipoproteins". Biomeditsinskaya Khimiya 60, n.º 3 (2014): 348–53. http://dx.doi.org/10.18097/pbmc20146003348.
Texto completoMohamad, Suriyati, Nur Najihah Ismail, Hasnah Osman, Habibah A Wahab y Thaigarajan Parumasivam. "In Vitro Interactions of Costus speciosus (J. Koenig) Sm., Cymbopogon citratus (Dc. Ex Nees) Stapf. and Tabernaemontana coronaria (L.) Willd. with First-Line Anti-Tuberculosis Drugs Against Mycobacterium tuberculosis H37rv". Malaysian Journal of Pharmaceutical Sciences 19, n.º 2 (23 de noviembre de 2021): 171–78. http://dx.doi.org/10.21315/mjps2021.19.2.11.
Texto completoSarkar, Sampa y Dhiman Sarkar. "Potential Use of Nitrate Reductase as a Biomarker for the Identification of Active and Dormant Inhibitors of Mycobacterium tuberculosis in a THP1 Infection Model". Journal of Biomolecular Screening 17, n.º 7 (9 de mayo de 2012): 966–73. http://dx.doi.org/10.1177/1087057112445485.
Texto completoKumar, Vipul, Jyoti Yadav, Aparna Parmar, Ritu Aggarwal y K. B. Gupta. "Study of rifampicin resistance among newly diagnosed pulmonary tuberculosis patients with type 2 diabetes mellitus: a prospective observational study". International Journal of Research in Medical Sciences 9, n.º 7 (25 de junio de 2021): 2035. http://dx.doi.org/10.18203/2320-6012.ijrms20212526.
Texto completoDey, Abhinav, Amit Kumar Verma y Dipankar Chatterji. "Role of an RNA polymerase interacting protein, MsRbpA, from Mycobacterium smegmatis in phenotypic tolerance to rifampicin". Microbiology 156, n.º 3 (1 de marzo de 2010): 873–83. http://dx.doi.org/10.1099/mic.0.033670-0.
Texto completoDo, Thi Thuy, Jerónimo Rodríguez-Beltran, Esmeralda Cebrián-Sastre, Alexandro Rodríguez-Rojas, Alfredo Castañeda-García y Jesús Blázquez. "Inactivation of a New Potassium Channel Increases Rifampicin Resistance and Induces Collateral Sensitivity to Hydrophilic Antibiotics in Mycobacterium smegmatis". Antibiotics 11, n.º 4 (12 de abril de 2022): 509. http://dx.doi.org/10.3390/antibiotics11040509.
Texto completoBondarenko, V. N., V. A. Shtanze y L. V. Zolotukhina. "CHARACTERISTICS OF <i>M.TUBERCULOSIS</i> DRUG RESISTANCE DETERMINED BY MOLECULAR GENETIC AND PHENOTYPIC METHODS". Health and Ecology Issues, n.º 3 (28 de septiembre de 2018): 61–66. http://dx.doi.org/10.51523/2708-6011.2018-15-3-12.
Texto completoDarma, Surya, Angga Ambara, Abu Tholib Aman, Luthvia Annisa, Nurrokhman, Titik Nuryastuti y Tri Wibawa. "High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients". PLOS ONE 15, n.º 11 (19 de noviembre de 2020): e0242542. http://dx.doi.org/10.1371/journal.pone.0242542.
Texto completoBourama Kané, Korotoumou Wélé Diallo, Boubacar Mami Touré, Oumou Koné, Guédiouma Dembélé, Sow Djénéba Sylla, Modibo Mariko et al. "Bacilliferous pulmonary tuberculosis of the infant: Report of 3 cases in the pediatrics department of the hospital of Mali". International Journal of Science and Research Archive 1, n.º 1 (30 de noviembre de 2020): 018–25. http://dx.doi.org/10.30574/ijsra.2020.1.1.0018.
Texto completoKhan, Javaid, Najmul Islam, Nadya Ajanee y Wasim Jafri. "Drug Resistance of Mycobacterium Tuberculosis in Karachi, Pakistan". Tropical Doctor 23, n.º 1 (enero de 1993): 13–14. http://dx.doi.org/10.1177/004947559302300107.
Texto completo